Tag Archives: Pyridines/pharmacology

Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression

Seeger FH, Sedding D, Langheinrich AC, Haendeler J, Zeiher AM, Dimmeler S. Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression. Basic Res Cardiol. May 2010;105(3):389-397. Publication Date May 2010 How Analyze was Used “For better anatomical orientation, the aorta and the heart…

In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism

Boothman L, Raley J, Denk F, Hirani E, Sharp T. In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol. December 2006;149(7):861-869. Full Text – Open Access Publication Date December 2006 How Analyze was Used “Data were transferred into ANALYZE-AVW imaging software and a standard volume of interest (VOI)…

A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment

Bantick RA, Montgomery AJ, Bench CJ, Choudhry T, Malek N, McKenna PJ, Quested DJ, Deakin JF, Grasby PM. A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment. J Psychopharmacol. September 2004;18(3):346-354. Publication Date September 2004 How Analyze was Used “Hand-placed regions were defined on these MRI images using Analy[z]e…

Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans

Coleman NS, Marciani L, Blackshaw E, Wright J, Parker M, Yano T, Yamazaki S, Chan PQ, Wilde K, Gowland PA, Perkins AC, Spiller RC. Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment Pharmacol Ther. November 2003;18(10):1039-1048. Full Text – Open Access Publication Date November 2003 How Analyze was…